Published: 6 May 2020
Author(s): Clara Benedetta Conti, Sonia Henchi, Giovanni Paolo Coppeta, Sophie Testa, Roberto Grassia
Issue: July 2020
Section: Letter to the Editor

A novel coronavirus (SARS CoV-2) spread in China in December 2019, becoming soon a relevant problem of international public health concern [1]. In Italy the SARS-CoV-2 officially spread around the 20th of February 2020 and the country became the first in Europe to register a high number of infections and deaths. The beta-coronavirus mainly creates a severe acute respiratory syndrome (COVID-19), with fever, cough, fatigue, pneumonia and acute respiratory distress syndrome, eventually. The patient management mainly focuses on supportive care: oxygenation, fluid management, and treatments with multiple drugs as antiviral therapies, chloroquine or hydroxyichloroquine, antibiotics, steroids, nonsteroidal anti-inflammatory drugs, bronchodilators and immunosuppressive drugs.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.